M-CSF as a therapeutic agent for thrombocytopenia

Details M-CSF as a therapeutic agent for thrombocytopenia M-CSF as a therapeutic agent for thrombocytopenia

1989-02-10

1992-05-19

Draper, Garnette D.

Drug, bio-affecting and body treating compositions

Lymphokine

514 2, 514 8, 514 12, 514 21, A61K 3702

Patent

active

051147106

ABSTRACT:
A therapeutic agent for thrombocytopenia due to hemopoietic disorder induced by various causes comprises as an active ingredient a specific human monocytemacrophage colony stimulating factor. It is administered for the treatment and/or prevention of such thrombocytopenia.

REFERENCES:
patent: 4230697 (1980-10-01), Nishida et al.
patent: 4275056 (1981-06-01), Takaku et al.
Cerretti et al, Molecular Immunology, vol. 25 (8) 1988, pp. 761-770.
McDonald et al, CA vol. 111, 1989, #117771k.
Anderson et al, CA vol. 110, 1989, #190839r.
Kuriya et al, CA vol. 106, 1986, #65243h.
Biological Abstracts, vol. 85, No. 6, 1988, p. AB-841, Abstract No. 60968.
Chemical Abstracts, vol. 107, No. 13, Sep. 13, 1987, p. 500, Abstract No. 114079r.

Affiliated with

Also associated with

Rating

M-CSF as a therapeutic agent for thrombocytopenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with M-CSF as a therapeutic agent for thrombocytopenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M-CSF as a therapeutic agent for thrombocytopenia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2416392